Pharmacokinetic Profiling of Pembrolizumab and Nivolumab in Patients With Melanoma and/or Non-Small Cell Lung Cancer

NCT05740501 · clinicaltrials.gov ↗

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Lung Non-Small Cell Carcinoma
Melanoma

Interventions

PROCEDURE: Biospecimen Collection
OTHER: Electronic Health Record Review
OTHER: Questionnaire Administration

Sponsor

Mayo Clinic